An Efficacy and Safety Study of Ha44 Gel Administered Topically for the Treatment of Head Lice Infestation

PHASE2CompletedINTERVENTIONAL
Enrollment

142

Participants

Timeline

Start Date

April 30, 2011

Primary Completion Date

August 31, 2011

Study Completion Date

March 31, 2012

Conditions
Pediculosis
Interventions
DRUG

Group A - Low-Dose Ha44 0.37% w/w

Low Dose Ha44 Gel applied to scalp and hair for 10 minutes

DRUG

Group B - High Dose Ha44 Gel 0.74% w/w

High Dose Ha44 Gel applied to scalp and hair for 10 minutes

DRUG

Group C - Placebo

Placebo- vehicle Ha44 Gel without active ingredient applied to scalp and hair for 10 minutes

Trial Locations (2)

90036

Axis Clinical Trials, Los Angeles

93618

Universal BioPharma Research Institute, Inc., Dinuba

All Listed Sponsors
lead

Dr. Reddy's Laboratories Limited

INDUSTRY